Sandoz

Pharmaceutical ManufacturingBasel, Basel-Stadt, Switzerland
Public Company17,137 Employees
Employees
~17,137

About Sandoz

Sandoz leads globally in generic and biosimilar pharmaceuticals. Our objective is to be the first in providing access to medications for patients worldwide. We aim to spur innovation within the healthcare sector by sustainably and responsibly unlocking resources, all while tackling worldwide health issues like antimicrobial resistance. We operate across over 100 countries, with our medicines reaching roughly 500 million individuals annually. Our operations are structured into two primary global divisions: Generics—spanning both standard and complex types—and Biosimilars.

Key Facts
Approximately 17,137 employees globally
Headquartered in Basel, Basel-Stadt, Switzerland
Operates in Pharmaceutical Manufacturing

Executive Leadership Team

Asaf Gal
Asaf Gal
Chief Technology Officer
Since 2023
Christophe DELENTA
Christophe DELENTA
President, Europe
Since 2024
Claire D'Abreu-Hayling
Claire D'Abreu-Hayling
Chief Scientific Officer
Since 2022
ET
Elizabeth Theophille
Chief Information and Digital Officer
Since 2025
Glenn A. Gerecke, PhD
Glenn A. Gerecke, PhD
Chief Manufacturing and Supply Officer
Since 2023
Ingrid Sollerer
Ingrid Sollerer
Chief Compliance Officer and General Counsel, Executive Committee Member
Since 2019

Organizational Chart — Preview

Powered by OrgKonnect
Live from OrgKonnect — bizkonnect.ai
See the Full Org Chart with Contact Details
Unlock reporting lines, direct contacts, connection paths, and business insights for all Sandoz's employees

Sandoz Executive Leadership Team

Asaf Gal
Asaf Gal
Chief Technology Officer
Since 2023
Christophe DELENTA
Christophe DELENTA
President, Europe
Leading the European business at Sandoz
Since 2024
Claire D'Abreu-Hayling
Claire D'Abreu-Hayling
Chief Scientific Officer
Since 2022
ET
Elizabeth Theophille
Chief Information and Digital Officer
Since 2025
Glenn A. Gerecke, PhD
Glenn A. Gerecke, PhD
Chief Manufacturing and Supply Officer
Since 2023
Ingrid Sollerer
Ingrid Sollerer
Chief Compliance Officer and General Counsel, Executive Committee Member
Since 2019

Business Focus Areas

Identified by BizNLP
Business Focus Areas
GenericsOver the counter medicinesBiosimilars
🔓 to see the full technographic profile including all applications, infrastructure details, vendor contracts, and technology evaluation signals.

Sandoz Org Chart & Organizational Structure

Sandoz, the global leader in generic and biosimilar medicines, is led by Chief Executive Officer Richard Saynor. The executive leadership team spans multiple business units and corporate functions, with direct reports to the CEO overseeing regional operations and global support areas. Regional presidents include Keren Haruvi Snir (President, Sandoz North America), Christophe DELENTA (President, Europe), Peter Stenico (President, Sandoz International Region), and Patrick Machan (Chief Executive Officer). Additionally, Simon Goeller serves as Chief Transformation and Growth Officer and Member of the Global Sandoz Leadership Team. Corporate functions reporting to the CEO include Finance, led by Remco Steenbergen (Chief Financial Officer, Group); Information Technology, led by Elizabeth Theophille (Chief Information and Digital Officer), with Asaf Gal serving as Chief Technology Officer under the Information Technology function; Research & Development, led by Claire D'Abreu-Hayling (Chief Scientific Officer); Human Resources, led by Tripti Jha (Chief People Officer, Sandoz AG); Sales, led by Rebecca Guntern (Chief Commercial Officer); Compliance, led by Ingrid Sollerer (Chief Compliance Officer and General Counsel, Executive Committee Member); and Supply Chain, led by Glenn A. Gerecke, PhD (Chief Manufacturing and Supply Officer). Tatiana Eliseeva serves as Chief Transformation Officer under both the Digital Transformation and Innovation and Strategy functions.